Reference values for healthy human myocardium using a T1 mapping methodology: results from the International T1 Multicenter cardiovascular magnetic resonance study-Reference-Cited by-同舟云学术

Reference values for healthy human myocardium using a T1 mapping methodology: results from the International T1 Multicenter cardiovascular magnetic resonance study

Published:2014-10-21 Issue:1 Volume:16 Page:
ISSN:1532-429X
Container-title:Journal of Cardiovascular Magnetic Resonance
language:en
Short-container-title:J Cardiovasc Magn Reson

Author:

Dabir Darius,Child Nicholas,Kalra Ashwin,Rogers Toby,Gebker Rolf,Jabbour Andrew,Plein Sven,Yu Chung-Yao,Otton James,Kidambi Ananth,McDiarmid Adam,Broadbent David,Higgins David M,Schnackenburg Bernhard,Foote Lucy,Cummins Ciara,Nagel Eike,Puntmann Valentina O

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging,Radiological and Ultrasound Technology

Link

https://link.springer.com/content/pdf/10.1186/s12968-014-0069-x.pdf

Reference39 articles.

1. Kwon DH, Halley CM, Carrigan TP, Zysek V, Popovic ZB, Setser R, Schoenhagen P, Starling RC, Flamm SD, Desai MY: Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function: a delayed hyperenhancement cardiac magnetic resonance study. JACC Cardiovasc Imaging. 2009, 2 (1): 34-44. 10.1016/j.jcmg.2008.09.010.

2. Schelbert EB, Cao JJ, Sigurdsson S, Aspelund T, Kellman P, Aletras AH, Dyke CK, Thorgeirsson G, Eiriksdottir G, Launer LJ, Gudnason V, Harris TB, Arai AE: Prevalence and prognosis of unrecognized myocardial infarction determined by cardiac magnetic resonance in older adults. JAMA. 2012, 308 (9): 890-896. 10.1001/2012.jama.11089.

3. Neilan TG, Coelho-Filho OR, Danik SB, Shah RV, Dodson JA, Verdini DJ, Tokuda M, Daly CA, Tedrow UB, Stevenson WG, Jerosch-Herold M, Ghoshhajra BB, Kwong RY: CMR quantification of myocardial scar provides additive prognostic information in nonischemic cardiomyopathy. JACC Cardiovasc Imaging. 2013, 6 (9): 944-954. 10.1016/j.jcmg.2013.05.013.

4. Gulati A, Jabbour A, Ismail TF, Guha K, Khwaja J, Raza S, Morarji K, Brown TD, Ismail NA, Dweck MR, Di Pietro E, Roughton M, Wage R, Daryani Y, O’Hanlon R, Sheppard MN, Alpendurada F, Lyon AR, Cook SA, Cowie MR, Assomull RG, Pennell DJ, Prasad SK: Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA. 2013, 309 (9): 896-908. 10.1001/jama.2013.1363.

5. Iles L, Pfluger H, Lefkovits L, Butler MJ, Kistler PM, Kaye DM, Taylor AJ: Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. J Am Coll Cardiol. 2011, 15 (57(7)): 821-828. 10.1016/j.jacc.2010.06.062.

Cited by 265 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Magnetic resonance mapping for the assessment of cardiomyopathies and myocardial disease;International Journal of Cardiology;2024-11

2. T2 mapping post acute myocardial infarction: a novel technique in assessing myocardial edema;Egyptian Journal of Radiology and Nuclear Medicine;2024-09-02

3. Computer-Assisted Algorithm for Quantification of Fibrosis by Native Cardiac CT: A Pilot Study;Journal of Clinical Medicine;2024-08-15

4. Dapagliflozin reduces systemic inflammation in patients with type 2 diabetes without known heart failure;Cardiovascular Diabetology;2024-06-07

5. Analysis of Myocardial T1, T2, and T2* Values by Age, Sex, and Cardiac Segments in Normal Population: A Prospective Study;2024-05-07